Search for other papers by Qiuli Liu in
Google Scholar
PubMed
Search for other papers by Gang Yuan in
Google Scholar
PubMed
Search for other papers by Dali Tong in
Google Scholar
PubMed
Search for other papers by Gaolei Liu in
Google Scholar
PubMed
Search for other papers by Yuting Yi in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
Search for other papers by Yao Zhang in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Yanfang Guan in
Google Scholar
PubMed
Search for other papers by Xin Yi in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
Introduction Von Hippel–Lindau (VHL) disease is a rare autosomal dominant disease that manifests as a variety of benign and malignant neoplasms, including retinal hemangioma (HB), HB of the central nervous system (CNS), pancreatic
Search for other papers by João Castro-Teles in
Google Scholar
PubMed
CINTESIS, Center for Health Technology and Services Research, University of Porto, Porto, Portugal
Search for other papers by Bernardo Sousa-Pinto in
Google Scholar
PubMed
Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Department of Clinical Pathology, Centro Hospitalar Universitário de São João (CHUSJ), Porto, Portugal
Search for other papers by Sandra Rebelo in
Google Scholar
PubMed
Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Endocrinology, Centro Hospitalar Universitário de São João (CHUSJ), Porto, Portugal
Search for other papers by Duarte Pignatelli in
Google Scholar
PubMed
Introduction Von Hippel–Lindau disease (vHL) is a rare hereditary autosomal dominant disorder resulting from the presence of pathogenic variants on the VHL gene ( 1 ), with a point prevalence estimated (as per the first nationwide study on
Department of Medicine IV, Medical Center – University of Freiburg
Search for other papers by Roland Därr in
Google Scholar
PubMed
Search for other papers by Jonas Kater in
Google Scholar
PubMed
Search for other papers by Peggy Sekula in
Google Scholar
PubMed
Search for other papers by Birke Bausch in
Google Scholar
PubMed
Search for other papers by Tobias Krauss in
Google Scholar
PubMed
Search for other papers by Christoph Bode in
Google Scholar
PubMed
Search for other papers by Gerd Walz in
Google Scholar
PubMed
Search for other papers by Hartmut P Neumann in
Google Scholar
PubMed
Search for other papers by Stefan Zschiedrich in
Google Scholar
PubMed
Introduction Von Hippel-Lindau (VHL) disease is an inherited autosomal-dominant tumour predisposition syndrome caused by inactivating mutations of the VHL tumour suppressor gene. The disorder is characterised by the frequent development of
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Uyen N P Duong in
Google Scholar
PubMed
Search for other papers by Ahmed M A Altibi in
Google Scholar
PubMed
Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed
Search for other papers by Thong Quang Pham in
Google Scholar
PubMed
Search for other papers by Hung Minh Tran in
Google Scholar
PubMed
Search for other papers by Greta Gandolfi in
Google Scholar
PubMed
Search for other papers by Lewis Hassell in
Google Scholar
PubMed
, 35 articles with a total of 17,732 PTC patients were included for final analysis ( Fig. 1 ). Figure 1 Study flowchart. DFS, disease-free survival; DSS, disease-specific survival; HR, hazard ratio; KMC, Kaplan Meier curve; VHL, Virtual Health
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Monica Livia Gheorghiu in
Google Scholar
PubMed
Search for other papers by Andrei Muresan in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Iuliana Gherlan in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Corin Badiu in
Google Scholar
PubMed
frequently described in the syndromes of multiple endocrine neoplasia (MEN) type 2A and type 2B, in certain families with von Hippel–Lindau disease ( VHL ) or in patients with MAX and TMEM127 gene mutation ( 3 , 7 ). Not all bilateral PHEOs are
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Search for other papers by Alberto Delgado Verdugo in
Google Scholar
PubMed
Search for other papers by Dan Granberg in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
of underlying molecular mechanisms in the tumorigenesis of these diseases has increased dramatically during the last decade (1) . Up to 80% of all PCC and PGL could have either germline or somatic mutations (2, 3, 4) in one of the 11 hitherto known
Search for other papers by Gemma White in
Google Scholar
PubMed
Search for other papers by Anand Velusamy in
Google Scholar
PubMed
Search for other papers by Samantha Anandappa in
Google Scholar
PubMed
Search for other papers by Michael Masucci in
Google Scholar
PubMed
Search for other papers by Louise A Breen in
Google Scholar
PubMed
Search for other papers by Mamta Joshi in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, King’s College London, London, UK
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Johnathan G H Hubbard in
Google Scholar
PubMed
Search for other papers by Rupert Obholzer in
Google Scholar
PubMed
Search for other papers by Dimitra Christodoulou in
Google Scholar
PubMed
Search for other papers by Audrey Jacques in
Google Scholar
PubMed
Search for other papers by Philip Touska in
Google Scholar
PubMed
Search for other papers by Fahim-Ul Hassan in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, King’s College London, London, UK
Search for other papers by Paul V Carroll in
Google Scholar
PubMed
SDHD carriers, respectively, at age of 60 years ( 5 ). In terms of location, SDHB -related tumours occur most commonly along the sympathetic chain, whereas SDHD -related disease predominantly affects the parasympathetic ganglia of the head and neck
Search for other papers by Yiqiang Huang in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Qiubo Xie in
Google Scholar
PubMed
Search for other papers by Jian Pang in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Yuting Yi in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
Search for other papers by Yao Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
a case of HIF2A germline-mutation-induced polycythemia in a patient with VHL-associated renal cell carcinoma ( 17 , 34 ). It is likely for this reason that the pseudohypoxia-related PCC/PGL is fundamentally a metabolic disease. In our study, the
Search for other papers by Natalie Rogowski-Lehmann in
Google Scholar
PubMed
Search for other papers by Aikaterini Geroula in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Felix Megerle in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Anthony Stell in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
blood pressure. Thereby, the disease represents a surgically correctable form of hypertension. As a consequence of the unpredictable hormone secretion, the tumors are potentially very harmful if not quickly diagnosed and treated. In fact, retrospective
Search for other papers by Catherine Cardot Bauters in
Google Scholar
PubMed
Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Search for other papers by Bruno Carnaille in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Stéphanie Espiard in
Google Scholar
PubMed
Search for other papers by Malo Penven in
Google Scholar
PubMed
Search for other papers by Evelyne Destailleur in
Google Scholar
PubMed
Search for other papers by Isabelle Szuster in
Google Scholar
PubMed
Search for other papers by Tonio Lovecchio in
Google Scholar
PubMed
CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France
Search for other papers by Julie Leclerc in
Google Scholar
PubMed
Search for other papers by Fredéric Frénois in
Google Scholar
PubMed
Search for other papers by Emmanuel Esquivel in
Google Scholar
PubMed
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Search for other papers by Emilie Ait-Yahya in
Google Scholar
PubMed
Search for other papers by Michel Crépin in
Google Scholar
PubMed
Search for other papers by Pascal Pigny in
Google Scholar
PubMed
). Thus, the KIF1Bβ neuronal pro-apoptotic effect combined with the mapping of KIF1B on chromosome 1p36, a region frequently deleted in PCC and NB ( 5 ), suggested that KIF1B might function as a tumor suppressor gene (TSG) in these diseases ( 3